New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
08:09 EDTACTI, TEVATeva decides not to proceed to randomization stage of trial for laquinimod
Active Biotech (ACTI) announces that its partner Teva Pharmaceuticals (TEVA), has decided not to proceed to the randomization stage of the planned Libretto trial for the treatment of Relapsing Remitting Multiple Sclerosis, or RRMS, as the current design is no longer aligned with the regulatory strategy. This decision has no impact on other ongoing studies, such as CONCERTO, which are proceeding as planned, or on Teva Pharmaceuticals' plans to initiate clinical studies in Primary Progressive Multiple Sclerosis, or PPMS.
News For ACTI;TEVA From The Last 14 Days
Check below for free stories on ACTI;TEVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
08:51 EDTTEVATeva says open to acquisitions, JVs in biosimilars
08:48 EDTTEVATeva says still has 'one of the best tax rates in the world'
Subscribe for More Information
08:32 EDTTEVATeva says delivering on cost reduction program, sees $2B in savings by 2017
Subscribe for More Information
07:04 EDTTEVATeva raises FY14 EPS view to $4.90-$5.10 in exclusive Copaxone scenario
Subscribe for More Information
07:03 EDTTEVATeva reports Q2 EPS $1.23, consensus $1.22
Subscribe for More Information
July 25, 2014
07:14 EDTTEVATeva August weekly volatility elevated into Q2 and outlook
Teva August weekly call option implied volatility is at 34, August is at 25, September and January is at 22; compared to its 26-week average of 27 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 31.
July 24, 2014
07:27 EDTTEVASome of Teva's biggest investors to vote against re-electing directors, WSJ says
Subscribe for More Information
06:45 EDTTEVATeva price target raised to $70 from $65 at Barclays
Subscribe for More Information
July 23, 2014
10:02 EDTTEVAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTTEVADeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTTEVATeva initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use